This site is intended for healthcare professionals only
Visken 10

Medicine composition:
Pindolol
Marketed by:
Novartis AG
Manufactured By :
Novartis AG
Medicine Type :
Allopathy
Prescription Type :
Prescription Required
Approval :
DCGI (Drugs Controller General of India)
Pharmacological Class :
Beta-Blocker,
Therapy Class:
Antihypertensive,
Schedule :
Schedule H

https://reference.medscape.com/drug/visken-pindolol-342362#4

https://www.webmd.com/drugs/2/drug-14386/pindolol-oral/details#:~:text=Some products that may interact,enzymes that remove this medication

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/018285s034lbl.pdf

Frishman WH. Pindolol: a new β-adrenoceptor antagonist with partial agonist activity. New England Journal of Medicine. 1983 Apr 21;308(16):940-4. Doi : 10.1056/NEJM198304213081606

Gugler, R., Herold, W. & Dengler, H.J. Pharmacokinetics of pindolol in man. Eur J Clin Pharmacol 7, 17–24 (1974). https://doi.org/10.1007/BF00614385:

Page Created On:   6 May 2023 12:06 PM GMT
Page Last Updated On:   2023-05-06 13:08:46.0